Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$1.2 - $2.19 $28,437 - $51,898
-23,698 Reduced 60.15%
15,700 $20,000
Q4 2022

Feb 02, 2023

BUY
$1.63 - $3.52 $7,572 - $16,353
4,646 Added 13.37%
39,398 $66,000
Q3 2022

Nov 04, 2022

SELL
$0.73 - $3.74 $9,131 - $46,783
-12,509 Reduced 26.47%
34,752 $108,000
Q2 2022

Aug 01, 2022

SELL
$2.2 - $4.2 $50,835 - $97,049
-23,107 Reduced 32.84%
47,261 $112,000
Q1 2022

May 10, 2022

BUY
$2.83 - $8.69 $199,141 - $611,497
70,368 New
70,368 $284,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.